Rectal Cancer | Q&A

Dr. Jonathan Efron, Director of the Division of Colorectal Surgery at Johns Hopkins Department of Surgery, answers important questions about rectal cancer, including minimally invasive surgical treatment options, advances in treatment of recurrent rectal cancer and consideration for genetic testing.    

Questions asked:

1. Why is it important for patients to be treated by a multidisciplinary team and comprehensive cancer program?
2. What are the minimally invasive treatment options for patients with rectal cancer?
3. What are the advances in treatment to manage recurrent rectal cancer?
4. When should patients be considered for genetic testing?

Created by

Johns Hopkins Medicine

Related Presenters

Jonathan Efron, MD

Jonathan Efron, MD

Director, Division of Colorectal Surgery
Associate Professor of Surgery

Director, Division of Colorectal SurgeryAssociate Professor of Surgery Expertise: Anorectal Disorders, Colon Cancer, Colorectal Surgery, Colostomy-sparing Surgery, Fecal Incontinence, General Surgery, Inflammatory Bowel Disease (IBD), ...

View full profile